Keywords: allogeneic; cardiac stem cell; ischemic cardiomyopathy; mesenchymal stem cell; ACCT; allogeneic cell combination therapy; BZ; border zone; CMR; cardiac magnetic resonance; CSCs; cardiac stem cells; EDV; end-diastolic volume; EF; ejection fraction; ESPVR;